“Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment

The increase in morbidity and mortality levels of cardiovascular diseases has resulted in the embracement of lipid management as a key component of secondary prevention. According to Cox (2009, p. 592), this scenario resulted in the publication of guidelines that stipulated how the secondary prevention of cardiovascular diseases will be carried out. The main concepts, applications, and the benefits of the knowledge in the article will be discussed in this synopsis.

The article is very informative since it encompasses all the knowledge from the guidelines set by the relevant government institutions. The role played by statins in the overall management of hyperlipidemia is emphasized, about coronary heart disease. The article focuses on explaining the importance of identifying persons at the greatest risk of cardiovascular disease (CVD) to direct treatment to minimize the risk factors (Cox, 2009, p.592).

Hyperlipidemia treatment is acknowledged as an important aspect in the reduction of risk associated with cardiovascular disease and in the management of patients who suffer from stroke. Simvastatin 40 mg is utilized as a part of the primary prevention. Treatment of risk factors with statins is recommended in the reduction of further events. The application of statins is the first step in secondary prevention since it reduces cholesterol synthesis and is cost-effective. Increasing the dosage to 80 mg or addition of Ezetimide should be done if suggested targets are not met within three months. Nicotinic acid and a fibrate are recommended for patients with low high-density lipoproteins (LPD). Lifestyle behaviors combined with pharmaceutical inventions offer fairly good results if carefully administered. The combination of statin or simvastatin 40 mg with other compounds has resulted in reductions in incidences of ischemic and hemorrhagic stroke (Cox, 2009, p.592-594).

The article has informative knowledge on the procedural utilization of statins and simvastatin in the management of hyperlipidemia. The knowledge is helpful to nursing practice since it helps the professionals know the procedures that are vital in the effective prevention of events associated with CVD. The comparison of different treatment options is vital since it provides a wide array of effective solutions in the reduction of mortality and morbidity (Cox, 2009, p.592). Information on the side effects in respect to the dosages is helpful particularly in the prescription of the drugs. It would help me to assess the patients for drug reactions before starting or increasing dosage. Advice on lifestyle behaviors would be informed by the effect of physical activity and diet on the level of lipids in the body (Cox, 2009, p.594).

The article is beneficial since it is an evidence-based summary that helps in the comparisons of various regimens in lipid management. The explanation on the stages when various dosages will be given and the expected side effects impact positively on my prior knowledge (Cox, 2009, p.593). This is particularly beneficial since it instills confidence needed during the discussions with the patient on the available therapeutic options. The dietary requirements would help in influencing policy on secondary prevention of CVD in the health care institutions (Cox, 2009, p.594).

The article offers in-depth information on the primary and secondary prevention of CVD which entails the analysis of various treatment options. It is very beneficial and applicable to the nursing practice since it provides new knowledge that is important in the effective management of CVD.

Reference List

Cox, B. (2009). Lipid management in secondary prevention. Practice Nursing, 20(12): 592-595.

Cite this paper

Select style

Reference

StudyCorgi. (2022, March 4). “Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment. https://studycorgi.com/lipid-management-in-secondary-prevention-hyperlipidemia-treatment/

Work Cited

"“Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment." StudyCorgi, 4 Mar. 2022, studycorgi.com/lipid-management-in-secondary-prevention-hyperlipidemia-treatment/.

* Hyperlink the URL after pasting it to your document

References

StudyCorgi. (2022) '“Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment'. 4 March.

1. StudyCorgi. "“Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment." March 4, 2022. https://studycorgi.com/lipid-management-in-secondary-prevention-hyperlipidemia-treatment/.


Bibliography


StudyCorgi. "“Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment." March 4, 2022. https://studycorgi.com/lipid-management-in-secondary-prevention-hyperlipidemia-treatment/.

References

StudyCorgi. 2022. "“Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment." March 4, 2022. https://studycorgi.com/lipid-management-in-secondary-prevention-hyperlipidemia-treatment/.

This paper, ““Lipid Management in Secondary Prevention”: Hyperlipidemia Treatment”, was written and voluntary submitted to our free essay database by a straight-A student. Please ensure you properly reference the paper if you're using it to write your assignment.

Before publication, the StudyCorgi editorial team proofread and checked the paper to make sure it meets the highest standards in terms of grammar, punctuation, style, fact accuracy, copyright issues, and inclusive language. Last updated: .

If you are the author of this paper and no longer wish to have it published on StudyCorgi, request the removal. Please use the “Donate your paper” form to submit an essay.